Series A startup

Who invested in Tongli Haiyuan Biotechnology

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Pharma

Funding summaryUpdated 26 Oct 2026

$13Mraised across 1 round since 2023, from 1 source

Latest round
Series A, $13MMar 2023
Investors
1
See who backed them

The rounds

  1. Mar 2023
    Series A$13M

    Source recorded

Everyone who backed them

Missing a round, or an investor who was in one? Tell us.

Quick answers about Tongli Haiyuan Biotechnology

Who invested in Tongli Haiyuan Biotechnology?

Tongli Haiyuan Biotechnology's investors include Fortune Venture Capital.

How much has Tongli Haiyuan Biotechnology raised?

Tongli Haiyuan Biotechnology has raised $13M across 1 round since 2023.

When did Tongli Haiyuan Biotechnology last raise?

Tongli Haiyuan Biotechnology's most recent round was a Series A of $13M in Mar 2023.

What was Tongli Haiyuan Biotechnology's biggest round?

Its most recent round, $13M in Mar 2023, is also its largest on record.

Who backed Tongli Haiyuan Biotechnology first?

Tongli Haiyuan Biotechnology's first round on record, in Mar 2023, was backed by Fortune Venture Capital.

What stage is Tongli Haiyuan Biotechnology at?

Tongli Haiyuan Biotechnology's latest named round is a Series A, in Mar 2023.

Companies like Tongli Haiyuan Biotechnology

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.